Why Institutions Are Turning Bullish on Biohaven—and the Catalyst That Could Unlock Its Value Apr 13, 2026 Life Science
Eli Lilly Writes a Check. AC Immune Surges 15%. Is This Strategy or Spare Change? Apr 7, 2026 Life Science
These Two Healthcare Dividend Stocks Offer a Safe Haven As Tech Stocks Keep Falling Apr 2, 2026 Life Science
This Popular ETF Quietly Boosted Its Healthcare Stake – High-Yield Dividend Stocks Are the New Favorite Mar 31, 2026 Life Science
Viking Therapeutics Approaches Make-or-Break Moment as Key GLP-1 Data Looms Mar 29, 2026 Life Science
High Volatility, High Reward: Two Biotech Stocks for the Risk-Tolerant Investor Mar 26, 2026 Life Science
Eli Lilly’s Weight-Loss Bet Comes With Risk. This ETF Offers a Smarter Alternative Mar 25, 2026 Life Science
April 10 Looms as Eli Lilly’s Next Big Test: Is the Stock a Buy Before the FDA Verdict? Mar 22, 2026 Life Science
